Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2023 event, please get in touch at 

The 6th IPF Summit is your opportunity to make meaningful connections face-to-face with experts in the field, and discuss how to overcome your current challenges to advance research and therapeutics for the 3 million patients suffering with IPF worldwide.

Join 150+ industry pioneers with the likes of Boehringer Ingelheim, Genentech, AbbVie, Gilead, Bayer, Lung Therapeutics, Galecto, Pliant Therapeutics, and United Therapeutics, in addition to the key opinion leaders such as Fernando Martinez, Naftali Kaminski, Toby Maher, and many more.

Spanning four days packed full of unrivaled content, they will be discussing all-things-IPF; from rethinking senescence to effectively repairing and regenerating lung tissue, to leveraging synthetic control arms in placebo-controlled trials.